FA
JAZZ icon

FDx Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

FDx Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,657
Closed -$236K – 724
2019
Q2 		$236K Buy
1,657
+202
+14% +$27.1K 0.01% 716
2019
Q1 		$208K Buy
+1,455
New +$190K 0.01% 726
2018
Q4 		– Sell
-1,536
Closed -$258K – 692
2018
Q3 		$258K Buy
1,536
+121
+9% +$20.8K 0.01% 750
2018
Q2 		$244K Buy
+1,415
New +$231K 0.01% 793
2016
Q4 		– Sell
-4,755
Closed -$578K – 1142
2016
Q3 		$578K Sell
4,755
-1,181
-20% -$159K 0.02% 572
2016
Q2 		$839K Sell
5,936
-543
-8% -$80K 0.04% 416
2016
Q1 		$846K Sell
6,479
-1,602
-20% -$199K 0.04% 420
2015
Q4 		$1.14M Buy
8,081
+1,621
+25% +$225K 0.05% 313
2015
Q3 		$858K Sell
6,460
-3,776
-37% -$650K 0.07% 288
2015
Q2 		$1.8M Buy
10,236
+2,336
+30% +$420K 0.09% 202
2015
Q1 		$1.37M Buy
7,900
+567
+8% +$97.3K 0.03% 470
2014
Q4 		$1.2M Buy
7,333
+199
+3% +$33K 0.07% 251
2014
Q3 		$1.15M Buy
7,134
+2,482
+53% +$382K 0.07% 286
2014
Q2 		$684K Buy
4,652
+1,887
+68% +$262K 0.04% 467
2014
Q1 		$383K Sell
2,765
-1,099
-28% -$165K 0.03% 524
2013
Q4 		$490K Sell
3,864
-90
-2% -$9.31K 0.05% 367
2013
Q3 		$364K Buy
+3,954
New +$319K 0.04% 373

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

FDx Advisors's JAZZ Position: Q3 2019 in Review

FDx Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2019, closing a stake of 1,657 shares — an estimated $236K sold.

FDx Advisors first reported a position in JAZZ in Q3 2013 and held it in 17 quarters. The position peaked at $1.8M in Q2 2015. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

  • FDx Advisors reported no remaining Jazz Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • FDx Advisors sold 1,657 Jazz Pharmaceuticals shares in Q3 2019, an estimated $236K.
  • FDx Advisors first reported a position in Jazz Pharmaceuticals in Q3 2013 and held it in 17 quarters.
  • FDx Advisors's Jazz Pharmaceuticals position peaked at $1.8M in Q2 2015.
  • 406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on FDx Advisors's 13F filing for Q3 2019, filed 7 Nov 2019.